Sooriya-28Dec2024-Health Che

Powered by
13.5L Customers | 8 Cities Accredited National Lab
Report
Patient Name : Mr. SOORIYA Reg. No. : PCL526455

Age and Sex : 17 Yrs / Male PCC Code : PCL-TS-622C
Referring Doctor : self Sample Drawn Date : 28-Dec-2024 08:15 AM
Referring Customer : O26OGM Registration Date : 28-Dec-2024 02:42 PM
Vial ID : R4495341 Report Date : 28-Dec-2024 04:50 PM
Sample Type : WB-EDTA Report Status : Final Report
Client Address :
HEMATOLOGY
HEALTH CHECK AT HOME - 33 TESTS
Test Name Obtained Value Units Bio. Ref. Intervals Method
(Age/Gender specific)
Complete Blood Count (CBC)

Haemoglobin 14.6 g/dL 13.0-17.0 Colorimetric
RBC Count 5.0 10^12/L 4.5-5.5 Electrical Impedance
Haematocrit (HCT) 42.3 % 40-50 Calculated
MCV 84.8 fl 83-101 RBC Histogram
MCH 29.3 pg 27-32 Calculated
MCHC 34.6 g/dL 31.5-34.5 Calculated
RDW-CV 14.5 % 11.6-14.0 RBC Histogram
Platelet Count 407 10^9/L 150-410 Electrical
Impedance/Microscopy
WBC count, Total 6.1 10^9/L 4.0-10.0 Impedance
Neutrophils 55.0 % 44-68 Microscopy
Neutrophil-Absolute Count 3.4 10^9/L 1.7-8.0 Calculated
Lymphocytes 37.0 % 25-48 Microscopy
Lymphocytes-Absolute Count 2.3 10^9/L 1.0-6.2 Calculated
Monocytes 5.0 % 0-9 Microscopy
Monocytes-Absolute Count 0.3 10^9/L 0.0-1.2 Calculated
Eosinophils 3.0 % 0-7 Microscopy
Eosinophils-Absolute Count 0.2 10^9/L 0.0-0.9 Calculated
Basophils 0.0 % 0-2 Microscopy
Basophils-Absolute Count 0.0 10^9/L 0.0-0.3 Calculated
Others 0.0 % 00 Microscopy
Remarks --
Sample is Processed on Automated CBC Analyzer
Note: Haematocrit (HCT) is derived from calculated MCV based on RBC Histogram as per Manufacturer's Manual
Page 1 of 5
Note: If the test results are alarming or unexpected,Client is advised to contact the laboratory immediately for possible remedial action.
Powered by
Report

Vial ID : R4495343, R4495339 Report Date : 28-Dec-2024 09:07 PM
Sample Type : Serum, Plasma-Sodium Fluoride- Report Status : Final Report
Client Address :
CLINICAL BIOCHEMISTRY
*Urea 15.0 mg/dL 18.0-45.0 Calculated

Comments:
Urea is the end product of the Protein metabolism. It is systhesised in Liver from the Ammonia produced by the catabolism of amino acids.
It is transported by the Blood to the Kidneys from where it is excreted.
Increased levels are found in renal diseases, urinary obstructions, shock, congestive Heart failure and burns.
Decreased levels are found in Liver failure and pregnancy.
*Creatinine 0.8 mg/dL 0.72-1.25 Kinetic Alkaline

Picrate
Comments:
Creatinine is the catabolic product of Creatinine Phosphate which is used by the skeletal muscle.
The daily production depends on muscular mass and it is excreted out of the body entirely by the Kidneys.
Elevated levels are found in renal dysfunction, reduced renal blood flow (shock, dehydration, congestive Heart failure), Diabetes, Acromegaly.
Decreased levels are found in Muscular Dystrophy.
*Glucose-Blood-Fasting 84.0 mg/dL Normal < 100 Hexokinase

Pre-diabetic 100-125
Diabetic >= 126
Comments:
Glucose is the major carbohydrate present in blood. Its oxidation in the cells is the source of energy for the body. Increased levels of Glucose are found in
Diabetes Mellitus, Hyperparathyroidism, Pancreatitis and renal failure.
Decreased levels are found in Insulinoma, Hypothyroidism, Hypopituitarism and extensive Liver disease
Biological Reference Interval : Source: American Diabetic Association, Diabetes Care 2018:41 (Suppl.1) S13-S27
*Insulin ( Fasting ) 11.2 mIU/L Insulin Fasting :2-25 CMIA

Comments:
Insulin is a protein hormone synthesized, stored and secreted by the Beta cells located in the Islets of Langerhans. Insulin is responsible for Glucose
concentration in blood.
Insulin deficiency is the crucial factor in the pathogenesis of type I Diabetes Mellitus.
Estimation of Insulin is useful in diagnosis of Insulinoma, fasting Hypoglycaemia.
Increased levels of Insulin are found in Insulinoma, Insulin autoimmune syndrome, Acromegaly, untreated mild Diabetes Mellitus in obese individuals.
Decreased levels of Insulin are found in Type I Diabetes Mellitus, Hypopituitarism, severe Diabetes Mellitus with Ketosis and weight loss.
Biological Reference Interval : Source: Williamas Textbook of Endocrinology, 13th ed. Philadelphia: Elsevier Saunders:2016.
Page 2 of 5
Powered by
Report

Vial ID : R4495343, R4495339 Report Date : 28-Dec-2024 09:07 PM
Sample Type : Serum, Plasma-Sodium Fluoride- Report Status : Final Report
Client Address :
*Thyroid Stimulating Hormone 1.59 µIU/mL 0.3-5.0 CLIA
(TSH)
Biological Reference Intervals : TSH(μlU/mL)
Pregnancy (As per American Thyroid Association)
1 Trimester 0.10-2.50
Interpretation:
Assay results should be interpreted in context to the clinical condition and associated results of other investigations.
Previous treatment with Corticosteroid therapy may result in lower TSH levels while Thyroid hormone levels are normal.
Results are invalidated if the client has undergone a radionuclide scan within 7-14 days before the test.
Abnormal Thyroid test findings often found in critically ill clients should be repeated after the critical nature of the condition is resolved.
The production, circulation, and disposal of Thyroid hormone are altered throughout the stages of pregnancy.
*Uric Acid 6.6 mg/dL 3.5 - 7.2 Uricase

Comments :
Uric acid is the end product of purine metabolism.

Uric acid is excreted to a large degree by the Kidneys and to a smaller degree in the intestinal tract by microbial degradation.
Increased levels are found in Gout, Arthiritis, impaired renal functions and starvation.
Decreased levels are found in Wilson’s Disease, Fanconis Syndrome and Yellow Atrophy of the Liver.
Result rechecked and verified for abnormal cases.

*** End Of Report ***
Page 3 of 5
Powered by
Report

Sample Type : Serum Report Status : Final Report
Client Address :
Lipid Profile
Cholesterol Total 171 mg/dL Adult: Desirable<200 mg/dL, Enzymatic
Borderline: 200 – 239 mg/dL,
High:>240 mg/dL
Cholesterol HDL 43 mg / dL 40 - 60 Direct
Homogenous
Cholesterol - LDL 112.6 mg/dL <100 Optimal Calculated
Cholesterol VLDL 15.4 mg/dL 7-40 Calculated
Non-HDL cholesterol 128 mg/dL Optimal < 130 Calculated
Triglycerides 77.0 mg/dL Normal: <150 Glycerol
Borderline High: 150–199 Phosphate
High: 200–499 Oxidase
Very High >500
Cholesterol Total/Cholesterol HDL 4.0 0 - 4.0 Calculated
Ratio
Cholesterol LDL/Cholesterol HDL 2.6 0 - 3.5 Calculated
COMMENTS: Therapeutic target levels of lipids as per NCEP – ATP III recommendations:
Total Cholesterol (mg/dL) <200 - Desirable, 200-239 - Borderline High, >240 - High
HDL Cholesterol (mg/dL) <40 - Low, >60 - High
LDL Cholesterol (mg/dL) <100 Optimal, [Primary Target of Therapy], 100-129 - Near Optimal/Above Optimal,
130-159 - Borderline High, 160-189 - High, >190 Very High
Serum Triglycerides (mg/dL) <150 Normal, 150-199 Borderline High, 200-499 High, >500 Very High
NCEP recommends lowering of LDL Cholesterol as the primary therapeutic target with Lipid lowering agents, however, if Triglycerides remain >200 mg/dL after LDL goal is reached, set
secondary goal for non-HDL Cholesterol (total minus HDL) 30 mg/dL higher than LDL goal.
When Triglyceride level is > 400 mg/dL, Friedewald Equation is not applicable for calculation of LDL & VLDL. Hence the calculated values are not provided for such samples.
ATP III Guidelines:
Risk Category LDL Goal LDL Level at Which to LDL Level at Which to Consider Drug Therapy
Initiate Therapeutic
Lifestyle Changes (TLC)
CHD or CHD <100 mg/dL >100 mg/dL >130 mg/dL (100-129 mg/dL: drug optional)*
RiskEquivalents(10-year risk
>20%)
2+ Risk Factors <130 mg/dL >130 mg/dL 10-year risk 10-20%: >130 mg/dL 10-year risk <10%:>160mg/dL
(10-year risk <20%)
0-1 Risk Factor <160 mg/dL >160 mg/dL >190 mg/dL (160-189 mg/dL: LDL-lowering drug optional)
Page 4 of 5
Powered by
Report

Sample Type : Serum Report Status : Final Report
Client Address :
Urea / Creatinine Ratio
Urea 15.0 mg/dL 18.0-45.0 Calculated
Creatinine 0.8 mg/dL 0.72-1.25 Kinetic Alkaline
Picrate
Urea / Creatinine Ratio 18.75 mg/mg Elevated ratio: >100:1 Calculated
Reduced ratio: <40:1
Correlate Clinically. Result rechecked and verified for abnormal cases.

*** End Of Report ***
Page 5 of 5

Sooriya-28Dec2024-Health Che

Uploaded by

Copyright:

Available Formats

Sooriya-28Dec2024-Health Che

Uploaded by

Document Information

Copyright

Available Formats

Share this document

Share or Embed Document

Sharing Options

Did you find this document useful?

Is this content inappropriate?

Copyright:

Available Formats

Sooriya-28Dec2024-Health Che

Uploaded by

Copyright:

Available Formats

Powered by

13.5L Customers | 8 Cities Accredited National Lab

Patient Name : Mr. SOORIYA Reg. No. : PCL526455

Complete Blood Count (CBC)

13.5L Customers | 8 Cities Accredited National Lab

Patient Name : Mr. SOORIYA Reg. No. : PCL526455

*Urea 15.0 mg/dL 18.0-45.0 Calculated

*Creatinine 0.8 mg/dL 0.72-1.25 Kinetic Alkaline

*Glucose-Blood-Fasting 84.0 mg/dL Normal < 100 Hexokinase

*Insulin ( Fasting ) 11.2 mIU/L Insulin Fasting :2-25 CMIA

13.5L Customers | 8 Cities Accredited National Lab

Patient Name : Mr. SOORIYA Reg. No. : PCL526455

*Uric Acid 6.6 mg/dL 3.5 - 7.2 Uricase

Uric acid is the end product of purine metabolism.

Result rechecked and verified for abnormal cases.

13.5L Customers | 8 Cities Accredited National Lab

Patient Name : Mr. SOORIYA Reg. No. : PCL526455

13.5L Customers | 8 Cities Accredited National Lab

Patient Name : Mr. SOORIYA Reg. No. : PCL526455

Correlate Clinically. Result rechecked and verified for abnormal cases.

You might also like